The role of UBE2C in the aggressive progression of various cancers, including tongue squamous cell carcinoma, renal cell carcinoma, thyroid carcinoma, and glioma, has been well‐documented.50 This evidence concerns the gene UBE2C and hereditary clear cell renal cell carcinoma.